FR2513126B1 - Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain - Google Patents

Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain

Info

Publication number
FR2513126B1
FR2513126B1 FR8214595A FR8214595A FR2513126B1 FR 2513126 B1 FR2513126 B1 FR 2513126B1 FR 8214595 A FR8214595 A FR 8214595A FR 8214595 A FR8214595 A FR 8214595A FR 2513126 B1 FR2513126 B1 FR 2513126B1
Authority
FR
France
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8214595A
Other languages
English (en)
French (fr)
Other versions
FR2513126A1 (fr
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2513126A1 publication Critical patent/FR2513126A1/fr
Application granted granted Critical
Publication of FR2513126B1 publication Critical patent/FR2513126B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR8214595A 1981-08-27 1982-08-25 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain Expired FR2513126B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
FR2513126A1 FR2513126A1 (fr) 1983-03-25
FR2513126B1 true FR2513126B1 (fr) 1986-04-18

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8214595A Expired FR2513126B1 (fr) 1981-08-27 1982-08-25 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain

Country Status (20)

Country Link
JP (1) JPS5846024A (xx)
AU (1) AU551879B2 (xx)
BE (1) BE894185A (xx)
CA (1) CA1176158A (xx)
CH (1) CH650679A5 (xx)
DE (1) DE3232034A1 (xx)
DZ (1) DZ452A1 (xx)
FR (1) FR2513126B1 (xx)
GB (1) GB2104382B (xx)
IE (1) IE54119B1 (xx)
IL (1) IL66611A0 (xx)
IT (1) IT1153182B (xx)
LU (1) LU84359A1 (xx)
MW (1) MW3882A1 (xx)
NL (1) NL192192C (xx)
NZ (1) NZ201682A (xx)
PH (1) PH19361A (xx)
SE (1) SE460334B (xx)
ZA (1) ZA826159B (xx)
ZW (1) ZW17482A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
EP0280534B1 (en) * 1987-02-25 1993-04-21 Novo Nordisk A/S Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
US8263551B2 (en) 2004-11-22 2012-09-11 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
JP5765813B2 (ja) 2008-09-19 2015-08-19 ウェルズ ファーゴ バンク ナショナル アソシエイション 治療用ペプチドのポリマーコンジュゲート
WO2011146518A2 (en) 2010-05-17 2011-11-24 Cebix Inc. Pegylated c-peptide
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
CH650679A5 (de) 1985-08-15
SE460334B (sv) 1989-10-02
FR2513126A1 (fr) 1983-03-25
NZ201682A (en) 1985-08-16
NL192192C (nl) 1997-03-04
GB2104382B (en) 1984-12-19
JPS5846024A (ja) 1983-03-17
MW3882A1 (en) 1984-07-11
IT8223017A0 (it) 1982-08-27
DE3232034C2 (xx) 1991-04-11
SE8204873L (sv) 1983-02-28
NL192192B (nl) 1996-11-01
AU8759482A (en) 1983-03-03
CA1176158A (en) 1984-10-16
IE822064L (en) 1983-02-27
DZ452A1 (fr) 2004-09-13
AU551879B2 (en) 1986-05-15
IT1153182B (it) 1987-01-14
DE3232034A1 (de) 1983-03-10
ZW17482A1 (en) 1982-11-17
IE54119B1 (en) 1989-06-21
LU84359A1 (fr) 1983-02-28
ZA826159B (en) 1984-04-25
GB2104382A (en) 1983-03-09
SE8204873D0 (sv) 1982-08-25
PH19361A (en) 1986-04-02
BE894185A (fr) 1983-02-24
NL8203315A (nl) 1983-03-16
IL66611A0 (en) 1982-12-31

Similar Documents

Publication Publication Date Title
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
FR2513126B1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain
BE894188A (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaine
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
BE894187A (fr) Formulations pharmaceutiques comprenant de l'insuline humaine un c- peptide humain et de la pro-insuline humaine
FR2511866B1 (fr) Formulations pharmaceutiques de pro-insuline humaine
IT1165553B (it) Composizione farmaceutica con attivita' antiaterosclerotica e procedimento per la sua preparazione
IT8420759A1 (it) Composizione ad attivita' farmaceutica perfezionata e sua utilizzazione per usi veterinari
IT1157306B (it) Vaccino contro le brucellosi umane e procedimento per la sua preparazione
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
BE885510A (fr) Medicament omni-potent dans la therapeutique contre la sclerose en plaque et l'arterio-sclerose
JO1236B1 (en) Pharmacy formulations that include human insulin and a human-c-peptide